All blog posts
Total 181 results for
Showing 72 out of 181 results
12 maio 2020
Patent and Pharma Update, May 2020
06 maio 2020
Update on medicines and medical devices regulation in the EU and the UK and the impact of COVID-19
30 abril 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
28 abril 2020
3D Trade Marks: Further guidance from the CJEU regarding shapes necessary to give a technical result
22 abril 2020
The UK will not participate in the UPC confirms IP Minister responding to House of Lords' letter
08 abril 2020
COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)
08 abril 2020
COVID-19: Pressure Points: A Catalyst for Collaboration (Global)
03 abril 2020
COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)
03 abril 2020
UK HC confirms that public interest grounds to refuse or limit an injunction to be used sparingly
02 abril 2020
CJEU finds Amazon not liable for direct infringement by unwittingly stocking infringing goods being sold through its website
01 abril 2020
European Commission strategy for data and AI: Shaping a digital future
30 março 2020
What’s next for the UPC project? Our analysis following the German Federal Constitutional Court decision
Showing 72 out of 181 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London